Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer
Clinical trial NCT03986294 · UNKNOWN
Trial details
- NCT number
- NCT03986294
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2022-01-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.